Abstract:This study depicted the metabolite and microbiota trajectories across aging. Long‐lived subjects from the familial longevity cohort harbored a distinguished microbiome signature. A candidate metabolite, pinane thromboxane A2 (PTA2), was consistently higher in the individuals of familial longevity and their descendants. Functional analysis showed PTA2 enhanced an anti‐inflammatory phenotype, indicating a protective role of PTA2 toward host health. Our findings provide insights into the association between gut microbiome and longevity and may facilitate the development of strategies for healthy aging. Gut microbiota associated with longevity plays an important role in the adaptation to damaging stimuli accumulated during the aging process. The mechanism by which the longevity‐associated microbiota protects the senescent host remains unclear, while the metabolites of the gut bacteria are of particular interest. Here, an integrated analysis of untargeted metabolomics and 16S rRNA gene sequencing was used to characterize the metabolite and microbiota profiles of long‐lived individuals (aged ≥90 years) in comparison to old‐elderly (aged 75–89 years), young‐elderly (aged 60–74 years), and young to middle‐aged (aged ≤59 years) individuals. This novel study constructed both metabolite and microbiota trajectories across aging in populations from Jiaoling county (the seventh longevity town of the world) in China. We found that the long‐lived group exhibited remarkably differential metabolomic signatures, highlighting the existence of metabolic heterogeneity with aging. Importantly, we also discovered that long‐lived individuals from the familial longevity cohort harbored a microbiome distinguished from that of the general population. Specifically, we identified that the levels of a candidate metabolite, pinane thromboxane A2 (PTA2), which is positively associated with aging, were consistently higher in individuals with familial longevity and their younger descendants than in those of the general population. Furtherly, functional analysis revealed that PTA2 potentiated the efficiency of microglial phagocytosis of β‐amyloid 40 and enhanced an anti‐inflammatory phenotype, indicating a protective role of PTA2 toward host health. Collectively, our results improve the understanding of the role of the gut microbiome in longevity and may facilitate the development of strategies for healthy aging.

Can longer lifespan be associated with gut microbiota involvement in lipid metabolism?

Bifidobacterium Adolescentis Regulates Catalase Activity and Host Metabolism and Improves Healthspan and Lifespan in Multiple Species

Bifidobacterium adolescentis improves lifespan and healthspan by regulating catalase activity and oxidative stress-associated metabolites

Does Microbiome Contribute to Longevity? Compositional and Functional Differences in Gut Microbiota in Chinese Long-Living (>90 Years) and Elderly (65-74 Years) Adults

Longevity-Associated Core Gut Microbiota Mining and Effect of Mediated Probiotic Combinations on Aging Mice: Case Study of a Long-Lived Population in Guangxi, China

Age-Related Changes in the Gut Microbiota Modify Brain Lipid Composition

Identification of fecal microbiome signatures associated with familial longevity and candidate metabolites for healthy aging

The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging – relevant neural and immune function

Consistent signatures in the human gut microbiome of longevous populations

Gut Microbe-Metabolite Profiles Are Associated with Microbial Pathways of Longevity in Women: A Cross-Sectional Study Conducted in China

Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice

The metabolic and endocrine impact of diet-derived gut microbiota metabolites on ageing and longevity

Identification of gut microbiome signatures associated with longevity provides a promising modulation target for healthy aging

Decreased Enterobacteriaceae translocation due to gut microbiota remodeling mediates the alleviation of premature aging by a high‐fat diet

Gut Microbiota Predicts Healthy Late-Life Aging in Male Mice

Microbial Genetic Composition Tunes Host Longevity

The Trajectory of Successful Aging: Insights from Metagenome and Cytokine Profiling

Dietary Genistein Increases Microbiota-Derived Short Chain Fatty Acid Levels, Modulates Homeostasis of the Aging Gut, and Extends Healthspan and Lifespan

A lipidome landscape of aging in mice

Age-related Compositional Changes and Correlations of Gut Microbiome, Serum Metabolome, and Immune Factor in Rats

Transplant of microbiota from long-living people to mice reduces aging-related indices and transfers beneficial bacteria